Navigation Links
Gentris Corporation Expands Headquarters, Biorepository
Date:9/13/2012

MORRISVILLE, N.C., Sept. 13, 2012 /PRNewswire/ -- Gentris Corporation (www.gentris.com), a global leader in pharmacogenomics and biorepository solutions, announced today the completion of a significant expansion to their Morrisville, N.C. facility. The first phase of the expansion included additional office space and a large, multipurpose conference room, which will accommodate scientific training and education programs. The second phase of construction tripled the available capacity of the clinical sample biorepository in order to meet future demand.

Gentris continues to invest in capabilities and capacity to address the growing personalized medicine market. As more pharmaceutical companies pursue biomarker-driven therapeutic strategies, there is a growing need to collect and store patient samples for analysis. The expanded biorepository will ensure sufficient capacity to accommodate the sample storage and management needs of pharmaceutical clients that are implementing pharmacogenomics in clinical trials. In addition to biorepository space, Gentris has added a large conference room to host scientific training and education programs that will focus on providing up-to-date information on best practices for integrating pharmacogenomics into drug development.

Eric Hall, Gentris VP of Clinical Operations and Biorepository Services, will be chairing a session on Strategic Specimen Tracking as part of the Biorepository track at the Clinical Business Expo 2012 in Boston on September 19-20.

Related Links: www.gentris.com

Quotes:

"As demand for clinical sample storage grows, we needed a larger, dedicated facility for sample management and biosrepository functions," said Eric Hall, Gentris VP of Clinical Operations and Biorepository. "Pharmaceutical companies are increasingly recognizing the value of banking clinical trial samples for immediate or future testing. By tripling the size of our biorepository space, we have increased our flexibility to manage and store a large number of diverse sample types and serve our rapidly expanding client base."

"We anticipate an increased need for biorepository and pharmacogenomics testing services as pharmaceutical companies invest in personalized medicine," said Scott Clark, Gentris Chief Scientific Officer. "The recent expansion will enable us to continue providing high quality solutions to our clients as well as to host training and education programs focused on maximizing the benefits of integrating pharmacogenomics and biobanking into clinical trials."

About Gentris Corporation:

Founded in 2001, Gentris is located in Research Triangle Park, NC, where it provides pharmacogenomics and biorepository support for all phases of clinical studies and genomic biomarker programs.  The Company works with academic and industry leaders to translate innovations in pharmacogenomics into safer, more effective medicines, which can lead to accelerated drug development and improvement in patient care globally.


'/>"/>
SOURCE Gentris Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Gentris Corporation Announces Collaboration to Study Blood Stability
2. Gentris Corporation Launches New Pharmacogenomics Services
3. Gentris Corporation Partners with the Shanghai Institutes of Preventative Medicine
4. Luminex Corporation To Present At Upcoming Investment Conferences In September
5. Genelex Corporation Rolls Out Lifesaving DNA Healthcare System
6. Tranzbyte Corporation Acquires the Exclusive Right to Market Low-Cost, Innovative MRI machines in North and South America
7. American Pacific Corporation Completes Redemption Of $40 Million Of Senior Notes
8. NextDocs Corporation Announces Trial Exchange, a Clinical Portal Designed Specifically for Clinical Trial Sites and Integrated with eTMF
9. Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco
10. Faruqi & Faruqi, LLP is Investigating AmerisourceBergen Corporation on Behalf of its Shareholders
11. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
Breaking Medicine News(10 mins):